GORD and dyspepsia Flashcards

1
Q

Define dyspepsia

A

A complex of upper GI symptoms which are typically present for four or more weeks inc. upper abdo pain, heartburn, acid reflux, nausea and/or vomiting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define gastro-oesophageal reflux disease (GORD)

A

A chronic condition where there is reflux of gastric contents (particularly acid, bile, and pepsin) back into the oesophagus, causing predominant symptoms of heartburn and acid regurgitation
Proven GORD = endoscopically-determined reflux disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What causes GORD? (4)

A

1) Transient relaxation (reduced tone) of the lower oesophageal sphincter
2) Increased intra-gastric pressure (for example straining and coughing)
3) Delayed gastric emptying
4) Impaired oesophageal clearance of acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Risk factors for GORD (8)

A
  • Stress and anxiety
  • Smoking and alcohol
  • Trigger foods (coffee, chocolate, fatty foods)
  • Obesity
  • Drugs that decrease LOS pressure e.g. a-blockers, anti-cholinergics, BZDs, beta blockers, bisphosphonates, calcium-channel blockers, corticosteroids, NSAIDs, nitrates, theophyllines, and TCAs
  • Pregnancy
  • Hiatus hernia
  • Family history
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Risk factors for Barrett’s oesophagus (4)

A
  • Male
  • Long duration and/or increased frequency of GORD symptoms
  • Previous oesophagitis or hiatus hernia
  • Previous oesophageal stricture or ulcers
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Complications of GORD

A
Oesophageal ulcers
Oesophageal haemorrhage
Anaemia due to chronic blood loss
Oesophageal stricture
Aspiration pneumonia
Barrett's oesophagus 
Dental erosions, gingivitis, and halitosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Causes for dyspepsia

A
GORD
Peptic ulcer disease
Functional dyspepsia
Barrett's oesophagus
Upper GI malignancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What to ask in history of dyspepsia?

A

Ask about any alarm symptoms
Assess the frequency, duration, and pattern of symptoms, and the impact on QOL
Ask about any family history of upper GI malignancy
Ask about any lifestyle factors that may cause or exacerbate symptoms, such as obesity, trigger foods, pattern of eating
Ask about smoking, alcohol, stress, anxiety, depression
Review the medication
Previous episodes, meds tried, inc abx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Exam for person with dyspepsia

A

Weight
Signs of anaemia
Abdo masses or tenderness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Differentials for dyspepsia

A
Upper gastrointestinal malignancy
Gallstones
Cholecystitis
Pancreatitis
Cardiac disease/angina
Gastroenteritis
Coeliac disease
Crohn's disease
Irritable bowel syndrome
Small intestine bacterial overgrowth
Abdominal aortic aneurysm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Dyspepsia initial management

A

1) Lifestyle measures e.g. weight loss, avoiding triggers, eating smaller meals, eating 4 hours before bed, smoking cessation, reduce alcohol, help with anxiety/depression
2) Review medication - advise antacid and/or alginate for short-term symptom control
3) Offer one of the following - full dose PPI for 1 month OR test for H pylori. If positive for H pylori, prescribe 1st line eradication therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What if dyspepsia symptoms persist/recur following initial management?

A

Switch to the alternative strategy (for example, offer a full-dose PPI for 1 month if the person has been tested for H. pylori infection and vice versa)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Initial detection of H pylori infection?

A

A carbon-13 urea breath test or stool antigen test - ensure the person has not taken a PPI in the past 2 weeks, or antibiotics in the past 4 weeks
OR
(Laboratory serological testing if above not available)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

First-line H. pylori eradication regimens

If a person tests postive for H. pylori, offer a 7-day triple therapy regimen of…

A
A PPI twice-daily 
and
amoxicillin 1 g twice-daily
and
Either clarithromycin 500 mg twice-daily or metronidazole 400 mg twice-daily.

If pen allergic, PPI, clarithromycin, and metronidazole
If pen allergic and previous exposure to clarithromycin, PPI, metronidazole and levofloxacin 250 mg twice-daily.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Typical PPI doses

A

Lansoprazole 30 mg, omeprazole 20–40 mg, esomeprazole 20 mg, pantoprazole 40 mg, or rabeprazole 20 mg.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How should I manage refractory or recurrent symptoms?

A

Assess for any new alarm symptoms
Consider alternative diagnosis
Check adherence and reinforce lifestyle advice
Consider alternative acid suppression therapy with a histamine (H2)-receptor antagonist (H2RA)
Consider the need for long-term acid suppression therapy
Consider re-testing for H pylori under special circumstances - if positive, need second line eradication therapy
May need referral for endoscopy/to gastro

17
Q

Who needs urgent endoscopy under 2 week wait pathway for dyspepsia?

A

All patients who’ve got dysphagia

All patients who’ve got an upper abdominal mass consistent with stomach cancer

Patients aged >= 55 years who’ve got weight loss, AND any of the following:
upper abdominal pain
reflux
dyspepsia

18
Q

Who needs non-urgent endoscopy for dyspepsia?

A

Patients with haematemesis

Patients aged >= 55 years who’ve got:
treatment-resistant dyspepsia
OR
upper abdominal pain with low haemoglobin levels
OR
raised platelet count with any of the following: nausea, vomiting, weight loss, reflux, dyspepsia, upper abdominal pain
OR
nausea or vomiting with any of the following: weight loss, reflux, dyspepsia, upper abdominal pain

19
Q

What is H pylori?

A

Helicobacter pylori

Gram negative bacteria

20
Q

What is Barrett’s oesophagus?

A

Columnar metaplasia of the distal oesophagus (replacing usual squamous epithelium) which has malignant potential and an 50-100x increased risk of developing oesophageal adenocarcinoma

21
Q

What is short and long Barrett’s?

A

Short <3cm
Long >3cm

(in relation to the affected segment)

22
Q

Risk factors for Barrett’s (4)

A

GORD
Male
Smoking
Central obesity

23
Q

How is Barrett’s managed?

A

Endoscopic surveillance with biopsies every 3-5 years if metaplasia
High-dose proton pump inhibitor
If dysplasia then endoscopic mucosal resecction or radiofrequency ablation

24
Q

Indications for upper GI endoscopy in GORD

A
age > 55 years
symptoms > 4 weeks or persistent symptoms despite treatment
dysphagia
relapsing symptoms
weight loss
25
Q

What if endoscopy is negative in GORD?

A

Consider 24-hr oesophageal pH monitoring (the gold standard test for diagnosis)

26
Q

Management of GORD (endoscopically proven)

A

Info and advice
Lifestyle measures - weight loss, avoid triggers, smaller meals etc, smoking cessation, reduce alcohol, sleep with bed raised, reducing stress
Review meds
Full dose PPI for 1-2 months
- if response then full dose treatment long-term, if no response then double-dose PPI for 1 month

27
Q

What is functional dyspepsia?

A

Dyspepsia symptoms and normal findings on endoscopy

28
Q

How do you manage functional dyspepsia?

A

Assess for any alarm symptoms
Offer written information and advice on the symptoms, self-care, and management options
Offer advice on lifestyle measures
Review the medication
Test the person for H. pylori infection - if positive, prescribe eradication therapy. If negative, offer low dose PPI or standard-dose H2RA for 1 month

29
Q

Symptoms of GORD

A
Heartburn (burning, retrosternal discomfort)
Belching
Acid/bile regurgitation
Increased salivation
Odynophagia
Asthma 
Cough
Hoarseness
Sinusitis
Dental erosions
30
Q

Define peptic ulceration

A

Gastric and duodenal ulceration collectively known as peptic ulcers

31
Q

Define gastric ulceration

A

Breach in the epithelium of the gastric mucosa that penetrates the muscularis mucosae, which is confirmed on endoscopy

32
Q

Define duodenal ulceration

A

Breach in the epithelium of the duodenal mucosa that penetrates the muscularis mucosae, which is confirmed on endoscopy

33
Q

Distinguish upper and lower GI bleeding

A

Upper GI bleeding = proximal to the ligament of Treitz, haematemesis or melaena, hyperactive bowel sounds, raised BUN/creatinine ratio, blood on NG aspiration

Lower GI bleeding = distal to ligament of Treitz, haematochezia (fresh blood PR), normal bowel sounds and BUN/creatinine ratio, NG aspiration clear

34
Q

Amoxicillin - dosing for H pylori, side effects, interactions (4), CIs, cautions

A

1g twice daily
S/Es - diarrhoea, nausea, vomiting, skin rash, anaphylaxis (rare)
Interactions - allopurinol (skin rashes), anticoagulants (prolongs prothrombin time), methotrexate (reduced excretion), tetracyclines
Contraindications - hypersensitivity
Caution - hypersensitivity to cephalosporins, hepatic impairment, CKD

35
Q

Clarithromycin - dosing for H pylori, side effects, interactions (4), CIs, cautions

A

500mg twice daily

S/Es - nausea, vomiting, abdominal discomfort, and diarrhoea, taste disturbance, headache, insomnia, hyperhidrosis, hepatotoxicity, rash, pancreatitis, QT interval prolongation, arrhythmias, Stevens-Johnson syndrome, toxic epidermal necrolysis, anaphylaxis

Interactions - carbamazepine, colchicine, drugs that prolong QT interval, drugs that cause hypokalaemia, itraconazole, ketoconazole, mirabegron, omeprazole, phenytoin, sildenafil, statins, theophylline, quetiapine, warfarin, antidiabetic drugs, CCBs

Contraindications - pregnancy, breastfeeding, severe hepatic and renal impairment, hypokalaemia, history of QT prolongation

Cautions - impaired hepatic function, CKD, CHD, severe cardiac insufficiency, bradycardia, hypomagnesaemia, myasthenia gravis

36
Q

Metronidazole - dosing for H pylori, side effects, interactions (4), CIs, cautions

A

400mg twice daily

S/Es - nausea and vomiting, anorexia, and very rarely hepatitis, jaundice, or pancreatitis. Taste disturbances, furred tongue, oral mucositis. Headache, ataxia. Thrombocytopenia, pancytopenia. Myalgia, arthralgia.
Darkening of urine. Rash, pruritus, and erythema multiforme. Drowsiness, dizziness, confusion, hallucinations, convulsions, or transient visual disorders.
Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN) or acute generalised exanthematous pustulosis (AGEP).

Common interactions - alcohol, anticoagulants, ciclosporin, cimetidine, lithium, phenytoin

Contraindications - hypersensitivity, Cockayne syndrome

Cautions - active or chronic severe peripheral and central nervous system disease, severe liver disease, alcohol dependency, pregnancy, breastfeeding